Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ETERNATEAR, INC.”

5 pharma patents match "ETERNATEAR, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "ETERNATEAR, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “ETERNATEAR, INC.” · 30,257 patents in full index Clear search

  1. US 12005139

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted

  2. US 11964047

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  3. US 11679078

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  4. US 11679079

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  5. US 11278493

    Ophthalmic formulations providing durable ocular lubrication

    ETERNATEAR, INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.